Results 171 to 180 of about 162,839 (298)

Long‐term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

BJS (British Journal of Surgery), EarlyView., 2020
This long‐term follow‐up study determined survival rates in a Swedish national cohort of 417 patients with breast cancer who all had neoadjuvant systemic therapy (NAST). Sentinel lymph node biopsy (SLNB) was performed before NAST in clinically node‐negative and after NAST in clinically node‐positive patients.
L. Zetterlund, F. Celebioglu, T. Hatschek, J. Frisell, J. de Boniface   +4 more
wiley   +1 more source

Possible role of anastrozole-induced hormonal alterations in pathogenesis of mammary apocrine carcinoma and follicular lymphoma: a case report and review of the literature. [PDF]

J Med Case Rep
Kitagawa Y, Nassiri M, Mesa H, Prakash J, Popnikolov N.   +4 more
europepmc   +1 more source

The Estrogenic Activity of Legume, Grass, and Corn Silage

, 1956
P. J. Pieterse, F. N. Andrews
openalex   +1 more source

OBSERVATIONS ON THE MINERAL METABOLISM OF PULLETS: XII. THE EFFECTS OF PROTRACTED TREATMENT WITH ESTROGEN AND WITH ESTROGEN PLUS ANDROGEN ON RETENTION OF SODIUM [PDF]

, 1959
Keith A Mccully, W. A. Maw, R. H. Common
openalex   +1 more source

Development of a Scoring System to Predict the Treatment Success for Nonoperative Management of Peptic Ulcer Perforation: A Secondary Data Analysis of PPAP Study

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Although surgical treatment is the primary measure for patients with perforated peptic ulcer (PPU), nonoperative management (NOM) has become a common alternative. However, risk score models predicting the success of NOM based on the analysis of a large number of patients remain scarce.
Kei Ito, Akira Endo, Hiromasa Hoshi, Koji Ito, Tomohiro Akutsu, Hikaru Odera, Hideto Shiraki, Takeshi Yokoyama, Yasukazu Narita, Taro Masuda, Akira Suekane, Shigeru Yamagishi, Koji Morishita   +12 more
wiley   +1 more source

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61". [PDF]

Pharmaceuticals (Basel)
Tassi A, Londero AP, Xholli A, Lanzolla G, Bertozzi S, Savelli L, Prefumo F, Cagnacci A.   +7 more
europepmc   +1 more source

Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined

Aggregate, EarlyView.
Non‐neoplastic diseases pose a significant health burden. Nanozymes, enzyme‐like nanomaterials, offer promising strategies for regulating oxidative stress and inflammation. This review explores their development, structure–function relationships, and therapeutic potential, with a focus on precision medicine through targeted delivery and multimodal ...
Ling Mei, Xikai Wang, Zhuang Hu, Jierui Yan, Xiaobo Wang, Haoran Wang, Ya Hou, Pengfei Zhang, Qihang Ding   +8 more
wiley   +1 more source

Molecular Mechanisms of Estrogens in the Induction of Epithelial-to-Mesenchymal Transition and Metastasis in Breast Cancer. [PDF]

Int J Mol Sci
Jiménez-Salazar J, Garcia-Melo L, Batina N, Alarcón-Aguilar A, Luna-López A, Hernández-Garcés P, Damián-Ferrara R, Damián-Matsumura P.   +7 more
europepmc   +1 more source

Machine‐Learning‐Guided Analysis of Breast Tumor Malignancy Based on Nuclear Morphological Features

Advanced Intelligent Discovery, EarlyView.
Through statistical and machine learning approaches, we evaluate a clinically relevant dataset comprising more than 500 instances of patient breast tumor nuclei with 10 size and shape features. Our study underscores the significance of nuclear morphological features as potential breast tumor malignancy biomarkers and their combined use with statistical
Aditi Birwadkar, Sophia Buttny, Célia Sahli, Kenry   +3 more
wiley   +1 more source

Steroid hormone regulation of immunometabolism and inflammation. [PDF]

Front Immunol
Smith LC, Ramar M, Riley GL, Mathias CB, Lee JY.   +4 more
europepmc   +1 more source